Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash Flows From Operating Activities:
Net income	$ 38,511	$ 7,829
Adjustments to reconcile net income to net cash flows used for operating activities:
Depreciation	41,822	36,544
Amortization	4,410	3,867
Deferred income taxes	(16,350)	(15,533)
Tax benefits from share-based payment arrangements	(21,759)	(13,238)
Share-based compensation	13,862	11,853
Increase (decrease) from changes in assets and liabilities, net of acquired assets and liabilities:
Accounts receivable	472,404	554,003
Inventories	(140,840)	(96,550)
Prepaid expenses and other current assets	(9,458)	(18,691)
Accounts payable, accrued liabilities, and income taxes payable	(442,654)	(273,439)
Other, net	(2,395)	(25,987)
Net cash flows (used for) provided by operating activities	(62,447)	170,658
Cash Flows From Investing Activities:
Purchases of tools, dies, and molds	(29,178)	(20,435)
Purchases of other property, plant, and equipment	(23,936)	(17,547)
Payments for acquisition, net of cash acquired		(684,522)
Proceeds from sale of other property, plant, and equipment	133	185
(Payments) proceeds from foreign currency forward exchange contracts	(12,619)	19,800
Net cash flows used for investing activities	(65,600)	(702,519)
Cash Flows From Financing Activities:
Payments of short-term borrowings, net	(9,844)	(8,018)
Proceeds from short-term borrowings, net	4,996
Payment of credit facility renewal costs	(4,015)
Payments of long-term borrowings	(350,000)
Proceeds from long-term borrowings, net	495,260
Share repurchases	(32,240)	(32,233)
Payment of dividends on common stock	(124,077)	(105,170)
Proceeds from exercise of stock options	57,311	75,601
Other, net	19,869	11,303
Net cash flows provided by (used for) financing activities	57,260	(58,517)
Effect of Currency Exchange Rate Changes on Cash	(5,412)	5,891
Decrease in Cash and Equivalents	(76,199)	(584,487)
Cash and Equivalents at Beginning of Period	1,335,711	1,369,113
Cash and Equivalents at End of Period	$ 1,259,512	$ 784,626